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Abstract 25 
Helicobacter pylori transactivates the epidermal growth factor receptor (EGFR) on gastric 26 
epithelial cells via a signalling cascade involving a disintegrin and metalloprotease 17 27 
(ADAM17) cleavage of membrane bound heparin binding-epidermal growth factor (HB-28 
EGF). The effects of H. pylori on ADAM17 C-terminus in epithelial cells have been 29 
examined. Total cellular ADAM17 and surface expression of ADAM17 were significantly 30 
increased by H. pylori in AGS gastric epithelial cells. These changes were associated with 31 
ADAM17 C-terminal phosphorylation at T375 and S791. AGS cells lacking the ADAM17 C-32 
terminal domain induced significantly attenuated cleavage of HB-EGF and were also unable 33 
to upregulate HB-EGF and EGFR transcripts to the same extent as cells expressing full length 34 
ADAM17. In mitotic unstimulated AGS and ADAM17 over-expressing AGS cells, 35 
ADAM17 was highly T735 phosphorylated indicating ADAM17 T735 phosphorylation is 36 
modified during the cell cycle. In conclusion, H. pylori induced ADAM17 C-terminal T735 37 
and/or S791 phosphorylation in gastric epithelial cells are likely to be an important trigger 38 
inducing ADAM17 activation and  shedding of  HB-EGF leading to EGFR transactivation. 39 
ADAM17 over-expression in gastric cancer represents a potential target for therapeutic 40 
intervention. 41 
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1. Introduction 50 
 The predominant cause of gastric cancer is chronic infection with the gastric bacterium 51 
Helicobacter pylori. The incidence of gastric cancer is highest in those with atrophic gastritis 52 
and intestinal metaplasia resulting from long-term H. pylori infection [1]. Potential 53 
contributory factors linking H. pylori with development of gastric cancer include the chronic 54 
inflammatory response to infection, H. pylori-induced perturbations in gastric epithelial cell 55 
signalling [2-5] and disruption of gastric epithelial cell intercellular and cell-matrix junctions 56 
[6].  57 
Gastric epithelial hyperproliferation is observed both clinically [7,8] and in animal models 58 
[9,10]. One of the potential mechanisms by which H. pylori induces hyperproliferative 59 
epithelial responses involves H. pylori stimulated transactivation of the Epidermal Growth 60 
Factor Receptor (EGFR). H. pylori strains both with, and without, the cag pathogenicity 61 
island (cag PAI) [11] transactivate the EGFR on gastric epithelial cells [12-16]. In line with 62 
the study of Prenzel et al, 1999, which identified that EGFR activation occurs via a Triple 63 
Membrane Passing Signal (TMPS) cascade [17], the EGF ligand heparin binding epidermal 64 
growth factor (HB-EGF) is essential for H. pylori stimulated EGFR transactivation and 65 
requires membrane metalloprotease and Mek1 activity for cleavage of membrane anchored 66 
pro-HB-EGF [12]. H. pylori stimulated cleavage of proHB-EGF and EGFR transactivation is 67 
mediated by ADAM17 [18]. 68 
ADAM17 was originally described as a tumour necrosis factor–alpha converting enzyme 69 
[19,20]. It has subsequently been shown to cleave numerous transmembrane proteins and is 70 
over expressed in tumours at many sites [21]. In gastric cancer both ADAM17 transcripts [22] 71 
and ADAM17 protein are increased [23,24] compared to non-involved gastric tissue and HB-72 
EGF is similarly upregulated in gastric cancer [25]. Our previous studies have shown that H. 73 
pylori infection upregulates ADAM17 transcripts in the gastric mucosa in vivo both clinically 74 
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[22] and in the gerbil H. pylori infection model [26]. In cultured gastric epithelial cells H. 75 
pylori stimulates increase in transcripts of several ADAM genes [27] and upregulation of 76 
ADAM17 transcripts is independent of a functional cag PAI [22].  77 
ADAM17 activity is regulated by multiple post-translational modifications including 78 
phosphorylation [21]. ADAM17 has three phosphorylation sites on its C-terminal 79 
cytoplasmic domain located at Threonine 735 (T735) and Serines 791 (S791) and 819 (S819). 80 
Phosphorylation at T735 regulates ADAM17 maturation and trafficking to the cell surface 81 
and is important for docking of Erk1/2 [28]. S791 and S819 also have a role in ADAM17 82 
activity. Phosphorylation of ADAM17 at S819 and dephosphorylation at S791 occurs 83 
following EGF stimulation of HeLa cells [29]. Phosphorylation of S819 is dependent on 84 
Erk1/2 while S791 dephosphorylation is not. There are varying results regarding the 85 
importance of the cytoplasmic tail for  ADAM17 enzymatic activity following exposure to 86 
different stimuli [28-33].   87 
Numerous pathogens transactivate the EGFR in epithelial cells yet little is known regarding 88 
their effects on the activation of the key ADAM proteins involved in EGFR transactivation 89 
[34]. H. pylori-induced EGFR transactivation can be mediated directly, or following 90 
pathogen-induced upregulation of other proteins capable of EGFR transactivation such as IL-91 
8 [35]. The aims of the present study were firstly to investigate the effects of H. pylori on 92 
upregulation of ADAM17 in epithelial cells and on C-terminus ADAM17 phosphorylation; 93 
and secondly to investigate ADAM17 substrate cleavage and autocrine EGFR signaling 94 
pathways in gastric epithelial cells over expressing ADAM17 and an ADAM17 C-terminus 95 
deficient mutant.   96 
 97 
 98 
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2. Materials and Methods 99 
2.1. Cell culture and transfections 100 
 AGS gastric epithelial cells, MKN28 and A431 human epidermoid carcinoma were cultured 101 
in RPMI 1640 medium (Gibco, Paisley, UK) containing 10% (v/v) heat inactivated fetal calf 102 
serum, 2 mM glutamine and 40 mg/ml gentamicin (Gibco, Paisley, UK) at 37ºC, 95% air and 103 
5%CO2. Where indicated, transfected cells were cultured with the addition of appropriate 104 
antibiotics. For transfection of AGS cells Lipofectamin2000 (Invitrogen, Paisley, UK) was 105 
used following the manufacturer’s instructions. The plasmid solution was added to AGS cells 106 
for 24h following replacement with media containing 500 μg/ml of appropriate selective 107 
antibiotic.  108 
2.2. Bacterial culture 109 
 H. pylori cag pathogenicity island (cag PAI) positive strains NCTC 11637, G27 and a G27Δ 110 
cagM
 
isogenic mutant (kindly provided by Dr. A. Covacci, Chiron Vaccines, Siena, Italy) 111 
were cultured on 8% (v/v) horse blood, 7.5% (w/v) agar plates (Oxoid base 2) with 50 μg/ml 112 
Amphotericin B at 37ºC in a microaerophilic atmosphere using the Campygen system 113 
(Oxoid, Hampshire, UK).  114 
2.3 Antibodies and plasmids 115 
 Antibodies used were mouse anti-ADAM17 monoclonal antibody (Abcam, Cambridge, UK), 116 
mouse anti-ADAM17 (M220) monoclonal antibody [36] kindly provided by Dr. R. Black, 117 
Amgen Inc., California, USA, rabbit anti-pADAM17 polyclonal antibodies targeting 118 
individually pThr735, pSer791 and pSer819 (GenScript, Piscataway, USA) and rabbit anti-119 
ERK1 polyclonal antibody (Santa Cruz, Heidelberg, Germany). Secondary antibodies Alexa 120 
Fluor 568 anti-rabbit and Alexa Fluor 488 anti-mouse (Invitrogen) were used. Plasmids used 121 
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were part of the Tet-off system (Clontech, France) and included pTet-off Advanced repressor 122 
plasmid, pTre-Tight-ADAM17 and pTre-Tight-ΔC-terminus ADAM17. To deactivate the 123 
over expression cells were cultured in the presence of 20 µg/ml of tetracycline. 124 
2.4 Bacterial-epithelial co-culture 125 
 MKN28, A341, AGS cells were seeded into 96-well plates (Nunc, Rochester, NY, USA) at a 126 
density of 3~5×10
4
 cells per well and cultured at 37°C in 95% air and 5%CO2 until 127 
80%~90% confluent. Prior to assay cells were cultured in serum free and antibiotic free 128 
medium for 24 hours. H. pylori G27 and G27ΔcagM were harvested into serum and 129 
antibiotic-free RPMI 1640 media, centrifuged at 1000 rpm for 10 min, re-suspended at 130 
5×10
7
/ml and used immediately. Bacteria were co-cultured in duplicate with MKN28, A431 131 
and AGS cells at a MOI of 100:1 for 1-6h. Untreated cells were used as negative controls at 132 
each time point. In some experiments epithelial cells were pre-incubated for 1h with 0.001-133 
1μM EKB-569 kindly provided by Dr. L. Greenberger (Wyeth Research Chemical Sciences, 134 
Pearl River, USA) before bacterial stimulation. 135 
2.5 “In Cell Western” assay 136 
 “In Cell Western” (ICW) assay was undertaken as previously described [14]. Following 137 
aspiration of media, the cells were fixed in 96 well plates with 3.7% (v/v) formaldehyde in 138 
phosphate buffered saline (PBS) for 20 min at 20
o
C. After cell permeabilisation by washing 139 
four times with 0.1% (v/v) Triton X-100 in PBS, nonspecific protein binding sites were 140 
blocked with Odyssey blocking buffer (LICOR Biosciences, Lincoln, NE, USA) for 1h 141 
before incubation for 2h with anti-ADAM17 monoclonal antibody (M220) and rabbit 142 
polyclonal anti-ERK1 diluted in blocking buffer. Following further washing cells were 143 
incubated for 1h in the dark with goat anti-mouse IgG Alexa Fluor 680 (Molecular Probes, 144 
Eugene, OR, USA) and goat anti-rabbit IRD800 antibody (Rockland, Gilbertsville, PA, USA) 145 
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before rewashing. Unstimulated control cells were included at each time point to determine 146 
endogenous ADAM17. A row of stimulated cells was included on every plate for incubation 147 
with secondary antibodies alone to determine any background levels of labelling. Plates were 148 
imaged on an Odyssey Reader (LICOR Biosciences) at 700nm and 800nm and data analysed 149 
using Odyssey Software 2.0. The 800nm value from ERK1 labelling was used to control for 150 
the intrawell variation in cell density and derive the 700nm Relative Value (Rel700) of 151 
ADAM17. The Rel700 value was used for comparisons between different cell lines with 152 
reference to unstimulated controls at each time point (100% standard).  153 
To evaluate surface ADAM17 an “On Cell Western” was performed where incubation with 154 
the ADAM17 antibody M220 against the extracellular domain [36] and secondary antibody 155 
labeling was undertaken without cell permeabilisation. Cells were subsequently 156 
permeabilised, labelled for ERK1, imaged at 700nm and 800 nm in an Odyssey Reader and 157 
analysed as above. Total cellular ADAM17 was measured by ICW on the same plate as the 158 
OCW assay to measure surface ADAM17 under identical experimental conditions. 159 
2.6 Immunofluorescent microscopy 160 
 AGS cells grown on sterile cover slips were stimulated either with H. pylori NCTC 11637 or 161 
G27 strains at MOI 100:1 for 90 min or with TNF-α 50 ng/ml (Sigma, Dorset, UK) for 15 162 
min at 37ºC. Unstimulated cells were used as controls. Cells were fixed with 4% (v/v) 163 
paraformaldehyde (Calbiochem, Darmstadt, Germany) and permeabilised with 0.1% (v/v) 164 
Triton X-100. Samples were labelled with primary antibodies followed by Alexa-flour 165 
conjugated secondary antibodies (Invitrogen) and DAPI (Invitrogen) and examined using a 166 
Nikon D-Eclipse C1 confocal microscope. Cells stained with secondary antibodies only and 167 
stained with non-immunised rabbit serum were used as negative controls. To confirm the 168 
specificity of the phosphorylation epitope  permeabilised cells were incubated prior to 169 
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immunolabelling with 10 U/ml phosphatase (Sigma) in 0.5M Tris-HCL buffer pH 8.5 170 
containing 1mM EDTA at 37°C for 1h. 171 
2.7 IRDye Near Infrared Fluorescence Resonance Energy Transfer assay (NIR-FRET) 172 
 To assay ADAM17 shedding activity in cell lines, a proTNF-α (SPLAQAVRSSSR) and 173 
proHB-EGF (LPVENRLY) synthetic NIR-FRET based peptide substrates were synthesised 174 
(kindly provided by Dr. Mike Olive, LI-COR Biosciences, Lincoln, NE, USA). The 175 
synthesised substrates were linked to IRDye 800 CW NHS Ester (LICOR Biosiences) and 176 
quenched with the non-fluorescent quencher IRDye QC-1 (LICOR Biosciences). Cleavage of 177 
the peptide substrate results in separation of the quencher and IRDye 800 CW and excitation 178 
at 780nm leads to the emission of  an Infrared signal at 810-830nm.  179 
AGS cells were seeded in a flat bottom 96-well plate (Corning, NY, USA) at cell density of 180 
2.5x10
5
 cells per ml, and incubated for 24h at 37ºC, 95% air 5% CO2 followed by incubation 181 
in antibiotic and serum-free media for 15h. FRET substrates were added at 40 nM for 3h and 182 
incubated in the dark at 37ºC, 95% air 5% CO2. Substrate diluted in media alone was used as 183 
a background control. Plates were centrifuged at 400g at 4ºC and cell free medium transferred 184 
to 96-well flat bottomed plates (Nunc, Paisley, UK). The OD of each well was read on an 185 
Odyssey reader at 800nm and data analysed with Odyssey 2.0 Software after subtracting 186 
background substrate only readings from test wells. Following fixation and permeabilisation 187 
nuclear staining of AGS cells with DRAQ5 DNA stain and reading in the 700nm channel 188 
normalised for differences in cell density. 189 
2.8 Polymerase chain reaction (PCR) 190 
 Cellular RNA was isolated using Bioline RNA isolation kit (Bioline, London,UK) as per the 191 
manufacturer’s protocol. cDNA was prepared from 2.5μg RNA using MMLuV reverse 192 
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transcriptase (NEB, Ipswich, USA) and 1μg random hexamer primers. For Quantitative Real-193 
Time Polymerase chain reaction (qRT-PCR) RNA isolation and cDNA synthesis was as 194 
above. Quantitative RT-PCR and data analysis was performed as described previously using 195 
SYBR Green I [37]. Primers used are listed in Table 1. 196 
2.9 Fluorescence activated cell sorting (FACS) 197 
 FACS analysis of cell cycle using propidium iodide was performed and labelling with rabbit 198 
polyclonal antibodies to pADAM17-T735, pADAM17-S791, pADAM17-S819. Cells were 199 
fixed with 1% paraformaldehyde, permeabilised with 0.5% saponin and blocked with 5% 200 
bovine serum albumin. Cells were incubated individually with the three rabbit polyclonal 201 
antibodies to pADAM17 followed by Alexa conjugated secondary antibody (Invitrogen, 202 
Paisley, UK). Following RNA degradation with RNAse A, propidium iodide was used to 203 
stain cellular DNA and permit cell cycle determination. Following the selection of intact cells 204 
stained with PI and the exclusion of doublets a plot of PI intensity (y axis) against the number 205 
of events (x axis) was created. 206 
2.10 Statistics 207 
 All data was initially analysed with the Kolmogorow-Smirnow test to determine if it was 208 
parametric. Parametric data was analysed by comparing each group to controls using t-test. 209 
Groups with p values below 0.05 were interpreted as significantly different from controls. 210 
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3. Results 211 
3.1 H. pylori stimulates ADAM 17 in epithelial cells independent of a functional cag PAI  212 
To extend results on H. pylori induced upregulation of ADAM17 transcripts in gastric 213 
epithelial cells [22], ADAM17 protein was quantified using “In Cell Western” analysis in 214 
AGS and MKN28 gastric epithelial cells and A431 cells following stimulation with the cag 215 
PAI+ H. pylori strain G27 and G27ΔcagM isogenic mutant. The 700nm Relative Value 216 
(Rel700) of unstimulated controls for each cell line at both 1 and 3h time points (defined as 217 
100% standard) was used for comparisons of changes in ADAM17 induced by H. pylori. In 218 
all three cell lines both G27 and the G27ΔcagM isogenic strain significantly increased 219 
ADAM17 in a time dependant manner (Figure 1A). Previous studies have demonstrated that 220 
G27ΔcagM fails to activate NF-κB [38] and IL-8 secretion in gastric epithelial cells [11]. The 221 
greatest increase in ADAM17 following H. pylori stimulation was observed in the AGS 222 
gastric epithelial cell line. 223 
As ADAM17 is produced as a pro-protein which undergoes maturation and cell trafficking to 224 
the cell membrane where ADAM17 acts as a sheddase [39], “On Cell Western” assays [40] 225 
were used to assess the effects of H. pylori infection on surface ADAM17 in AGS cells. 226 
ADAM17 immunolabelling of the extracellular domain of the protein was carried out in 227 
unpermeabilised AGS cells and following permeabilisation, total cellular ERK1 was 228 
measured to control for cell density variations. Parallel assays of total cellular ADAM17 were 229 
undertaken by ICW on the same assay plates under identical experimental conditions. In the 230 
OCW both the wild type strain G27 and the ∆cagM mutant significantly increased surface 231 
cell membrane ADAM17 (Figure 1B). At 1h post-stimulation there was a 90% increase in 232 
surface ADAM17 relative to unstimulated control cells following G27 stimulation and 100% 233 
increase following G27ΔcagM (Figure 1B). Whilst there was a temporal increase in total 234 
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cellular ADAM17 after bacterial stimulation as determined by the ICW assay over the course 235 
of the 6h experiment, the major increase in surface ADAM17 in the OCW assay was detected 236 
1h post-stimulation with G27 and the isogenic mutant G27 ΔcagM (Figure 1B).  237 
3.2 ADAM17 over expression in AGS gastric epithelial cells  238 
As H. pylori stimulated the highest ADAM17 levels in the AGS gastric epithelial cell line 239 
(Figure 1A), AGS cells were chosen for constructing ADAM17 over expression and C-240 
terminus deletion mutants. ADAM 17 has three phosphorylation sites located within its C-241 
terminus. To analyse the effects of H. pylori on ADAM17 activity and its C-terminal 242 
phosphorylation at T735, S791 and S819, AGS gastric epithelial cells over expressing both 243 
wild type and C-terminus deficient ADAM17 were constructed. The ΔC-terminus ADAM17 244 
mutant had a translational stop signal introduced resulting in the absence of the cytoplasmic 245 
tail and T735, S791 and S819 phosphorylation sites. Protein expression from plasmid 246 
constructs was controlled via a Tet-off system, which allowed for inducible over expression 247 
of ADAM17 in the absence of tetracycline. ADAM17 over expressing monoclones were 248 
selected and over expression validated using reverse transcription followed by PCR and 249 
immunofluorescence microscopy. Over expressed ADAM17 had the same cellular 250 
localisation profile as the endogenous ADAM17 and no compartmentalisation was observed. 251 
Due to the very high efficiency of ADAM17 overexpression we hypothesise that in these 252 
cells overexpressed ADAM17 will be the dominant clone and the biological driver.  253 
3.3 Phosphorylation of ADAM 17 at T735 is cell cycle dependant and induced by H. pylori 254 
and TNF-α 255 
Examination of the localisation of the three phosphorylated forms of ADAM17 (p-T735, p-256 
S719 and p-S819) in unstimulated AGS wild type cells and AGS cells over expressing 257 
ADAM17 was undertaken by immunofluorescent microscopy (Figure 2A and B) and  FACS 258 
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analysis (Figure 2C and D). High levels of ADAM17 phosphorylated at T735 were present in 259 
cells that were undergoing mitosis in both wild type AGS gastric epithelial cells (Figure 2A)  260 
and ADAM17 over expressing cells (Figure 2B) but this was not observed with ADAM p-261 
S719 or ADAM p-S819 immunofluoresence microscopy (data not shown). Confocal 262 
microscope analysis indicated that pT735ADAM17 constitutes approximately 7% of total 263 
ADAM17 in unstimulated cells and 32% and 39% of total ADAM17 respectively after TNF-264 
α  and H. pylori stimulation. pS791 constitutes 21% of total ADAM17 in unstimulated cells 265 
and 34% and 57% of total ADAM17 respectively following TNF-α and H. pylori stimulation.  266 
I would strongly advise to delete this section, reasons explained in the response to reviewers 267 
document. 268 
To quantify further the phosphorylation of ADAM17 at these three sites in relation to cell 269 
cycle, FACS analysis of cell cycle using propidium iodide (PI) was performed along with 270 
staining for each of the phosphorylated forms of ADAM17 in wild type AGS cells (Figure 271 
2C) and  ADAM17 over expressing AGS cells (Figure 2D). In AGS gastric epithelial cells 272 
treated with PI and the Alexa 488 conjugated secondary antibody only, there was a signal 273 
from the Alexa 488 indicating that there was some non-specific binding of the secondary 274 
antibody but the intensity of this staining was much lower than that for any of the primary 275 
phospho-ADAM17 antibody treated cells (Figure 2C and D). The PI intensity of AGS cells 276 
plotted against the intensity of ADAM17 phosphorylated at S791 or S819 indicated that 277 
phosphorylation of ADAM17 occurs at these sites but the AGS cells fell within one cluster 278 
suggesting phosphorylation at S791 and S819 was not linked to specific phases of the cell 279 
cycle. In contrast, co-staining with PI and an antibody against phospho-T735 identified two 280 
populations of cells in both wild type AGS cells (Figure 2C) and AGS ADAM17 over 281 
expressing cells (Figure 2D). Phospho-T735 was detected in the majority of cells and these 282 
cells were in all phases of the cell cycle, however a population of cells with high PI staining 283 
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in G2/M phase of the cell cycle had much higher expression of p-T735 (Figure 2C and 2D). 284 
Unstimulated AGS wild type cells and AGS cells over expressing ADAM17 had respectively 285 
0.95 + 0.16 (mean + SEM) % and 3.4 + 0.77 % (n = 4 independent experiments) of total cells 286 
with high expression of p-T735 in G2/M phase of the cell cycle (p <0.02).  These data 287 
confirm the findings of the immunofluorescence microscopy where high levels of p-T735 288 
were detected in AGS cells undergoing mitosis. This suggests that either phosphorylation of 289 
ADAM17 at T735 may have a role in regulating the cell cycle or that ADAM17 290 
phosphorylated at T735 plays some role in cell division. 291 
To investigate whether H. pylori induced phosphorylation of ADAM17 in AGS gastric 292 
epithelial cells, AGS  cells were cultured with H. pylori strain NCTC 11637 for 90 min and 293 
TNF-α (50ng/ml) for 15 min and cells were immunolabelled for ADAM17 and  phospho-294 
T735 and phospho-S719 ADAM17 (Figure 2E and F) and phospho-S819 ADAM17. 295 
Phosphorylation of ADAM17 T735 (Figure 2E) and ADAM17 S791 (Figure 2F) was 296 
stimulated by both H. pylori NCTC 11637 strain and TNF-α in AGS gastric epithelial cells. 297 
Similar results were observed with H. pylori G27 strain. Background levels of ADAM 298 
phospho-T735 positivity in unstimulated AGS cells were lower than that of phospho-S791 299 
ADAM17. Confocal microscope analysis indicated that pT735ADAM17 constitutes 300 
approximately 7% of total ADAM17 in unstimulated cells and 32% and 39% of total 301 
ADAM17 respectively after TNF-α  and H. pylori stimulation. pS791 constitutes 21% of total 302 
ADAM17 in unstimulated cells and 34% and 57% of total ADAM17 respectively following 303 
TNF-α and H. pylori stimulation. I would strongly advise to delete this section, reasons 304 
explained in the response to reviewers document, also this is a repetition. Pre-incubation of 305 
permeabilised cells with phosphatase prior to immunolabelling confirmed specificity of 306 
phospho-T735 and S791 ADAM17 antibodies for phosphorylation epitopes. No specific 307 
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upregulation of phospho-S819 ADAM17 was observed with H. pylori or TNF-α stimulation 308 
(data not shown).  309 
3.4 C-terminus of ADAM 17 is required for substrate cleavage  310 
To evaluate the importance of ADAM17 phosphorylation in the TMPS cascade leading to 311 
EGFR transactivation, the ability of unstimulated AGS gastric epithelial cells, AGS cells over 312 
expressing  wild type ADAM17 or ΔC-terminus ADAM17 to cleave ADAM17 substrates 313 
was determined using an IRDye Near Infrared Fluorescence Resonance Energy Transfer 314 
assay (NIR-FRET). The cleavage of HB-EGF and TNF-α quenched probes by the AGS cell 315 
lines was examined. AGS ΔC-terminus ADAM17 induced a small but significant (p < 0.05) 316 
increase in HB-EGF cleavage compared to non-transfected AGS cells. In contrast, AGS cells 317 
over expressing ADAM17 significantly increased (p < 0.05) HB-EGF cleavage relative to 318 
both non-transfected AGS cells and AGS ΔC-terminus ADAM17 cells (Figure 3A). Analysis 319 
of cleavage of the ADAM17 substrate TNF-α using a TNF-α quenched probe showed that the 320 
AGS ΔC-terminus ADAM17 cell line was able to significantly (p < 0.05) increase TNF-α 321 
cleavage relative to that induced by non-transfected gastric epithelial AGS cells. However 322 
cleavage induced by the AGS ΔC-terminus ADAM17 cell line was significantly lower (p < 323 
0.05)  than that observed with AGS cells over expressing wild type ADAM17 (Figure 3B).  324 
 To investigate further the importance of the ADAM17 cytoplasmic tail and its 325 
phosphorylation sites in autocrine cell signalling, HB-EGF and EGFR transcripts in 326 
unstimulated AGS cells, AGS cells overexpressing ADAM17 and AGS cells with ΔC-327 
terminus ADAM17 were examined. Transfected cells were examined after culture with, and 328 
with out, tetracyline. Both ADAM17 over expressing wild type and ΔC-terminus ADAM17 329 
AGS cells had significantly (p < 0.01) increased abundance of HB-EGF and EGFR 330 
transcripts in the absence of tetracycline compared to AGS epithelial cells (Figure 4A and B).  331 
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However both HB-EGF and EGFR transcript abundance was significantly (p < 0.05) higher 332 
in AGS cells over expressing ADAM17 than AGS cells with ΔC-terminus ADAM17 in cells 333 
cultured in the absence of tetracycline (Figure 4A and B).  This demonstrates that ADAM17 334 
over expression in gastric epithelial cells in the absence of H. pylori stimulation will 335 
upregulate key components of the TMPS pathway promoting autocrine EGFR signalling. 336 
3.5 H. pylori-induced ADAM17 upregulation in epithelial cells is not blocked by EGFR 337 
inhibition  338 
To examine whether H. pylori-induced upregulation of ADAM17 was dependent on EGFR 339 
transactivation, A431 cells were pre-incubated with the selective EGFR tyrosine kinase 340 
inhibitor EKB-569 for 1h at 37°C before co-culture with H. pylori. In contrast to results on H. 341 
pylori stimulated ERK1/2 phosphorylation [14], EKB-569 had no effect on H. pylori induced 342 
ADAM17 upregulation at 3 hours post-infection. There was no effect of EKB-569 on 343 
endogenous ADAM17 in uninfected A431 cells (Figure 5). 344 
345 
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4. Discussion 346 
The activity of ADAM17 can be post-translationally regulated via a number of different 347 
cellular processes. These include post-translational modifications such as phosphorylation, 348 
targeted degradation, enzymatic cleavage and inhibition by TIMPs [39]. It has been 349 
hypothesised that ADAM17 phosphorylation is required for its activation and hence would be 350 
required for H. pylori activation of ADAM17 during the TMPS cascade leading to EGFR 351 
transactivation.  352 
Previous studies have shown ERK-mediated phosphorylation of T735 ADAM17 induces 353 
trafficking of ADAM17 to the surface of COS-7 cells [28]. Our previous studies using “In 354 
Cell Western” assays have shown maximal ERK1/2 phosphorylation in AGS gastric 355 
epithelial cells occurs 90 min following stimulation with H. pylori G27 strain and 356 
G27∆cagM [14]. In the present study using “On Cell Westerns” and ICW assays a significant 357 
increase in both cell surface and total ADAM17 in AGS epithelial cells was observed 358 
following culture with H. pylori G27 strain and G27∆cagM. The OCW cell-based assay is a 359 
recently developed valuable tool which allows rapid quantitative monitoring of changes in 360 
cell surface protein expression [40]. With G27 stimulation total cellular ADAM17 increased 361 
over 6h. With both G27 and G27∆cagM stimulation the majority of the increase in surface 362 
ADAM17, as determined by OCW assay, was evident 1h after bacterial stimulation 363 
indicating a rapid surface translocation of ADAM17. Additionally, H. pylori-upregulation of 364 
ADAM17 in the AGS gastric epithelial cells was independent of a functional cag PAI, 365 
concurring with previous reports on H. pylori-stimulated ERK1/2 activation [14].   366 
ADAM17 is active only on the cell membrane where it works as a sheddase [21,39]. After H. 367 
pylori stimulation, both the ADAM17 T735 and S791 phosphorylation status increased. H. 368 
pylori-induced ADAM17 phosphorylation at T735 and S791 in gastric epithelial cells was 369 
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observed 90min post-infection, a time point concomitant with maximal H. pylori-induced 370 
ERK activation [14]. These results on H. pylori-induced ADAM17 phosphorylation of T735 371 
and increased cell surface ADAM17 fit the model proposed by Soond et al (2005) that ERK-372 
mediated ADAM17 T735 phosphorylation is important in ADAM17 trafficking and 373 
maturation [28]. However whilst the EGFR inhibitor EKB-569 reduces H. pylori stimulated 374 
ERK1/2 phosphorylation in vitro [14], the present study indicates that upregulation of 375 
ADAM17 by H. pylori was independent of EGFR transactivation occurring in the presence of 376 
the EGFR inhibitor EKB-569. Both pERK1/2 dependent and independent H. pylori activation 377 
of ADAM17 is likely to occur. 378 
The present results indicate ADAM17 T735 phosphorylation could be involved in H. pylori-379 
induced EGFR transactivation in gastric epithelial cells [12]. Additionally, the observation 380 
that AGS cells transfected with ADAM17 lacking the C-terminus stimulated reduced 381 
cleavage of HB-EGF and TNF-α quenched probes compared  to  AGS cells transfected with 382 
wild type ADAM17 also supports a role for ADAM17 phosphorylation sites in surface 383 
proHB-EGF cleavage leading to EGFR transactivation. In addition, reduction in EGFR and 384 
HB-EGF transcripts in unstimulated AGS cells transfected with ΔC-terminus ADAM17 385 
compared to cells transfected with wild type ADAM17 suggests ADAM17 phosphorylation, 386 
and over expression in gastric cancer cells, will promote autocrine EGFR signalling. In 387 
addition to the current studies with H. pylori, ADAM17 activation has also been observed in 388 
airway epithelial cells following culture with pulmonary bacteria [41]. However, the current 389 
study with H. pylori is the first report on ADAM17 phosphorylation as a result of bacterial 390 
stimulation. 391 
ADAM17 was previously found to co-localise to membrane ruffles [42]. During Golgi 392 
transport, ADAM17 is inserted into lipid rafts for removal of the prodomain by furin [43]. 393 
This results is active ADAM17 and increased levels of its substrates within lipid rafts [43]. 394 
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When cholesterol is depleted, ADAM17 increases substrate shedding, highlighting the 395 
importance of cholesterol in ADAM17 regulation via substrate availability and spacial 396 
organisation [43].  397 
Recently H. pylori has been shown to extract cholesterol rapidly from lipid rafts in epithelial 398 
plasma membranes in a cag PAI independent manner for subsequent glucosylation and 399 
immune evasion [44]. The resulting destruction of lipid rafts as a consequence of H. pylori 400 
cholesterol extraction could be a potential trigger for ADAM17 phosphorylation and 401 
increased sheddase activity. It would also explain why in the present study the EGFR 402 
inhibitor EKB-569 failed to modify H. pylori-induced ADAM17 upregulation. 403 
  However, both ADAM17 [42,45] and the H. pylori protein CagL protein [46] bind α5β1 404 
integrin. Additionally H. pylori protein CagL can directly interact with ADAM17 leading to 405 
ADAM17 dissociation from the α5β1 integrin resulting in ADAM17 dependent pro-HB-EGF 406 
cleavage [47]. Both the disruption of lipid rafts in epithelial cells by H. pylori [44] and 407 
upregulation of ADAM17 transcripts [22] and ADAM17 protein in gastric epithelial cells, as 408 
observed in the present study, was independent of a functional cag PAI. Further studies are 409 
required to evaluate fully the effect of cholesterol depletion on H. pylori induced ADAM17 410 
shedding and EGFR activation. 411 
The present study has also identified that ADAM17 T735 phosphorylation is cell cycle 412 
dependent and ADAM17 T735 phosphorylation is markedly upregulated during mitosis in 413 
gastric epithelial cells. This, to our knowledge, is the first observation of phosphorylated 414 
ADAM17 T735 being associated with mitosis. Interestingly, earlier yeast two-hybrid studies 415 
showed ADAM17 binds to the protein MAD2 (mitotic arrest deficient 2), a component of the 416 
mitotic checkpoint mechanism [48]. The screen identified MAD2 as a binding partner to 417 
ADAM17 cytoplasmic domain containing residues 706-740 [48]. Further investigation is 418 
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necessary to determine if the MAD2 interaction is dependant on T735 phosphorylation of 419 
ADAM17.  420 
In summary, these studies have identified the importance of the ADAM17 C-terminal domain 421 
in H. pylori stimulated TMPS which results in EGFR transactivation. ADAM17 C-terminal 422 
ADAM17 T735 and S791 phosphorylation in gastric epithelial cells is induced by H. pylori. 423 
ADAM17 T735 phosphorylation is modified in the cell cycle being markedly upregulated in 424 
mitotic cells. ADAM17 over-expression in gastric cancer represents a potential target for 425 
therapeutic intervention. 426 
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Table 1: Primer sequences. 572 
Target 
Gene 
Direction Sequence 5’-3’ 
EGFR F dAGTGACTGCTGCCACAACCAGTGTGCTGCAGGC 
EGFR R dGCCTTGCCGCAAAGTGTGTAACGG 
HB-EGF F dTGGTGCTGAAGCTCTTTCTGGCTGCAG 
HB-EGF R dCCAAGCCACAAGCACTGGCCACAC 
Actin F dTGCCCTGAGGCACTCTTCCAG 
Actin R dCACACGGAGTACTTGCGCTC 
ADAM 17 F dGTGGATAAGAAATTGGATAAACAG 
ADAM 17 R dGCGTTAGCACTCTGTTTCTTTGCTGTCAACACG 
573 
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Figure legends 575 
Figure 1. H. pylori strain G27 and G27ΔcagM stimulate ADAM17 in human epithelial 576 
cells. A)  MKN28, AGS gastric epithelial cells and A431 human epidermoid carcinoma cells 577 
were co-cultured with H. pylori cag PAI positive strain G27 and G27ΔcagM at MOI 100:1 or 578 
left unstimulated for 1 to 3h.  ADAM17 was quantified by “In Cell Western” (ICW) analysis 579 
using a mouse monoclonal antibody to ADAM17 and a rabbit-polyclonal ERK1 antibody. 580 
Fluorescence intensity was measured at 800 nm and 700nm using a Licor Odyssey imager. 581 
The 700nm Relative Value was obtained after normalisation with 800nm values to control for 582 
cell density variation. Individual cell line data are presented as mean + SEM (n = 4 - 7) of 583 
700/800 % Relative Response (Res700) with reference to unstimulated controls at each time 584 
point (100% standard). Statistical significance was analysed using t-test * p < 0.05; ** p < 585 
0.01. # p < 0.05 versus control; ## p < 0.01 versus control. B) “On Cell Western- In Cell 586 
Western” (OCW- ICW) and ICW assay of cell surface and total cellular ADAM17 587 
respectively in AGS gastric epithelial cells stimulated with H. pylori cag PAI positive strain 588 
G27, and G27ΔcagM at MOI 100:1 or left unstimulated for 1 to 6h. Cell surface ADAM17 589 
was measured in unpermeabilsed AGS cells by OCW using a mouse monoclonal antibody to 590 
the extracellular domain of ADAM17 as above. Following cell permeabilisation, total cell 591 
ERK-1 was measured using a rabbit polyclonal ERK1 antibody as above. ICW of ADAM17 592 
was measured as in A). OCW/ICW and ICW data are presented as mean + SEM (n = 4) of 593 
700/800% Relative Response (Res700) with reference to unstimulated controls (100% 594 
standard) at each time point. Statistical significance was analysed using t-test, * p < 0.05; ** 595 
p < 0.01.  596 
Figure 2. Phosphorylation of ADAM17 at T735 is cell cycle dependant and induced by 597 
TNF-α and H. pylori. (A) Immunofluorescence microscopy of AGS cells. Bar = 20µm. (B) 598 
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Immunofluorescence microscopy of AGS cells over expressing full length ADAM17, Bar = 599 
20µm. In both (A) and (B) DAPI nuclear stain (blue); total ADAM17 (green); ADAM17 600 
phosphorylated at T735 (red); followed by the merged image. Cells undergoing mitosis with 601 
high levels of pT735 are indicated with white arrow heads. (C) Cell cycle analysis of AGS 602 
cells and (D) AGS cells over expressing full length ADAM17 was undertaken using 603 
fluorescence activated cell sorting. Cells were fixed with 1% PFA, permeabilised with 0.5% 604 
saponin and blocked with 5% BSA. ADAM17 phosphorylated at T735, S791 and S819 was 605 
detected with rabbit antibodies α-ADAM17-pT735, α-ADAM17-pS791 and α-ADAM17-606 
pS819, respectively and an Alexa conjugated secondary antibody. Propidium iodide was used 607 
to stain the DNA and allow cell cycle phase determination. Contour plots of propidium iodide 608 
staining intensity (y axis) against the intensity of pADAM17 staining (x axis) are shown in C 609 
and D. (E) Immunofluorescence microscopy of AGS cells showing ADAM17 610 
phosphorylation at T735; total ADAM17 (green), pADAM17 T735 (red) and DAPI nuclear 611 
stain (blue), lower right hand image (merged). Bar= 20µm. Stimulation with both TNF-α and 612 
H. pylori increases ADAM17 T735 phosphorylation. (F) Immunofluorescence microscopy of 613 
AGS cells for ADAM17 phosphorylation at S791; total ADAM17 (green), pADAM17 S791 614 
(red) and DAPI nuclear stain (blue), lower right hand image (merged). Bar 20µm. In both (E) 615 
and (F) cells were either non-treated (Control) or stimulated with 50 ng/ml TNF-α for 15 616 
mins or H. pylori NCTC 11637 cag PAI+ at MOI 100:1, for 90 mins. 617 
Figure 3. C-terminus of ADAM17 is required for substrate cleavage. Cleavage of 618 
quenched fluorescent substrates with cleavage sites corresponding to (A) HB-EGF and (B) 619 
TNF-α by AGS gastric epithelial cells and AGS over expressing ADAM17 or ADAM17 ΔC-620 
terminus (ΔC-ter) was measured. Cells were incubated for 3h with quenched fluorescent 621 
substrates containing cleavage sites corresponding to HB-EGF or TNF-α. Fluorescence 622 
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intensity was measured at 800 nm using a Licor Odyssey imager. Error bars represent SEM 623 
of n = 3, statistical significance was analysed using t-test. * p < 0.05. 624 
Figure 4. ADAM17 deficient in its C-terminus does not increase EGFR and HB-EGF 625 
transcripts to the same extent as WT ADAM17 in gastric epithelial cells. (A-B) AGS 626 
gastric epithelial cells were transfected with wild type ADAM17 and C-terminus deficient 627 
ADAM17 mutant (ΔC-ter). Cells were cultured in both the presence (inhibited over 628 
expression [off]) and absence (active over expression [on]) of Tetracycline (as described in 629 
materials and methods). Untransfected AGS cells were included for comparison. Cellular 630 
RNA was isolated using Bioline RNA isolation kit. cDNA was prepared from 2.5 mg of RNA 631 
per sample. Transcript levels were analysed using qRT-PCR. (A) EGFR transcript levels 632 
relative to actin (B) HB-EGF transcript level relative to actin. Error bars represent SEM of n 633 
= 3, statistical significance between the cell lines was analysed using unpaired t-test. A paired 634 
t test was used for comparison of removal of tetracycline in ADAM17 over expressing cells 635 
and ΔC-terminus ADAM17 expressing cells. * p < 0.05, ** p < 0.01. 636 
Figure 5. H. pylori stimulation of ADAM17 in epithelial cells is not blocked by EGFR 637 
inhibition.  A431 human epidermoid carcinoma cells were pre-incubated with 0-1000nM 638 
EKB-569 for 1 hour before co-culture with H. pylori cag PAI positive strain G27 and 639 
G27ΔcagM at MOI 100:1 or left unstimulated for 1.5 to 3h.  ADAM17 was quantified by “In 640 
Cell Western” (ICW) analysis using a mouse monoclonal antibody to ADAM17 and a rabbit-641 
polyclonal ERK1 antibody. Fluorescence intensity was measured at 800 nm and 700nm using 642 
a Licor Odyssey imager. The 700nm Relative Value was obtained after normalisation with 643 
800nm values to control for cell density variation. Individual cell line data are presented as 644 
mean + SEM (n = 3) of 700/800 % Relative Response (Res700) with reference to 645 
unstimulated controls at each time point (100% standard). Statistical significance was 646 
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analysed using t-test * p < 0.05; ** p < 0.01; # p < 0.05 versus control; ## p < 0.01 versus 647 
control. 648 
